Format

Send to

Choose Destination
World J Gastroenterol. 2014 Nov 21;20(43):16079-94. doi: 10.3748/wjg.v20.i43.16079.

Gut microbiota and metabolic syndrome.

Author information

1
Davide Festi, Ramona Schiumerini, Leonardo Henry Eusebi, Giovanni Marasco, Martina Taddia, Antonio Colecchia, Department of Digestive Diseases and Internal Medicine, University of Bologna, S Orsola Hospital, 40138 Bologna, Italy.

Abstract

Gut microbiota exerts a significant role in the pathogenesis of the metabolic syndrome, as confirmed by studies conducted both on humans and animal models. Gut microbial composition and functions are strongly influenced by diet. This complex intestinal "superorganism" seems to affect host metabolic balance modulating energy absorption, gut motility, appetite, glucose and lipid metabolism, as well as hepatic fatty storage. An impairment of the fine balance between gut microbes and host's immune system could culminate in the intestinal translocation of bacterial fragments and the development of "metabolic endotoxemia", leading to systemic inflammation and insulin resistance. Diet induced weight-loss and bariatric surgery promote significant changes of gut microbial composition, that seem to affect the success, or the inefficacy, of treatment strategies. Manipulation of gut microbiota through the administration of prebiotics or probiotics could reduce intestinal low grade inflammation and improve gut barrier integrity, thus, ameliorating metabolic balance and promoting weight loss. However, further evidence is needed to better understand their clinical impact and therapeutic use.

KEYWORDS:

Bariatric surgery; Diabetes; Gut microbiota; Metabolic syndrome; Non-alcoholic fatty liver disease; Obesity; Prebiotic; Probiotic

PMID:
25473159
PMCID:
PMC4239493
DOI:
10.3748/wjg.v20.i43.16079
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Baishideng Publishing Group Inc. Icon for PubMed Central
Loading ...
Support Center